It’s no secret that drug manufacturers and distributors earn incredible profit margins on medication sales. Even when generic versions are …
Testosterone Gel Heart Attack Victim Wins $140MM Settlement
In October 2017, a Chicago jury ordered testosterone gel manufacturer AbbVie, Inc. to pay more than $140 million in damages. …
Cook Vena Cava Filter Bellwether Trial Update
The first Cook Medical inferior vena cava (IVC) filter bellwether trial just concluded — and the jury made a difficult …
Low T Fatalities Make Men Think Twice About Therapies
Low testosterone levels can cause significant health problems for aging men. All men experience a testosterone decline as they age. …
Low Testosterone Blood Clots and a Mistaken Fountain of Youth
For many men, aging brings lower testosterone levels. And in recent years, testosterone replacement therapies became an alluring fountain of …
Temporal Arteritis Study: Actemra Works 3x Better Than Corticosteroids
Inflammation within the arteries can cause a condition called giant cell arteritis (also known as temporal arteritis). For most patients, …
FDA Issues Updated Invokana Amputation Risk Warning
Most people who get diagnosed with type 2 diabetes don’t assume that amputation is in their future. One recent FAERS …
IVC Filter Indications: When Blood Thinners Won’t Do
Doctors often prescribe blood thinners to reduce pulmonary embolism (PE), blood clot, and deep vein thrombosis (DVT) risks. However, there …
Invokana Facts: 5 Things You Should Know
Invokana is an oral SGLT2 inhibitor medication used to treat type 2 diabetes. It was first released in 2013 and …
Invokana Litigation Update: 55 Claims Consolidated Under MDL 2750
Best-selling blood sugar drug Invokana® (generic: canagliflozin) can cause complications such as ketoacidosis and liver damage. Type 2 diabetics began …